argus

Alkem Laboratories Limited

NSE: ALKEMINE540L0101462,293 Cr

Timeline

Time (IST)TypeMEventSrc
05 Dec, 04:30 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
05 Dec, 04:04 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
05 Dec, 04:03 pmAlkem Laboratories Limited has informed the Exchange regarding Appointment of Mr Prakash Ramnani as Senior Management Personnel of the company w.e.f. December 05, 2025.nse
04 Dec, 01:39 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI .bse
04 Dec, 01:39 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
02 Dec, 02:49 pmAlkem Laboratories Limited has informed the Exchange about Sustainability Report for financial year 2024-2025nse
22 Nov, 09:17 pmThis is to inform you that GMP inspection by the Ministry of Health, Armenia had conducted an inspection at the Company s manufacturing facility located at Sikkim, India from 21st November, 2025 to 22nd November, 2025. The said inspection was concluded today with no critical or major observation. Kindly take note of the same.nse
20 Nov, 04:58 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
20 Nov, 04:56 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "Press Release Alkem launches probiotic DSS , the original De Simone formulation, in India for gut health management".nse
19 Nov, 11:55 amAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
19 Nov, 11:50 amAlkem Laboratories Limited has informed the Exchange about Transcriptnse
18 Nov, 05:19 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODR.bse
18 Nov, 05:08 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
13 Nov, 08:58 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Nov, 08:49 pmAlkem Laboratories Limited has informed the Exchange about Link of Recordingnse
13 Nov, 01:59 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Nov, 01:57 pmAlkem Laboratories Limited has informed the Exchange about Investor Presentationnse
13 Nov, 01:55 pmAlkem Laboratories Ltd - 539523 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025bse
13 Nov, 01:51 pmAlkem Laboratories Limited has informed the Exchange regarding Board meeting held on November 13, 2025.nse
13 Nov, 01:48 pmAlkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
13 Nov, 01:48 pmAlkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 13 November 2025bse
10 Nov, 07:02 pmAlkem Laboratories Limited has informed the Exchange about EU GMP inspection by German Health Authority at the Company s manufacturing facility located at Baddi, Indianse
03 Nov, 04:21 pmAlkem Laboratories Limited has informed the Exchange about Action(s) taken or orders passednse
03 Nov, 04:17 pmAlkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Orderbse
03 Nov, 02:24 pmAlkem Laboratories Limited has informed the Exchange regarding a revised press release dated November 03, 2025, titled "Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines".nse
03 Nov, 02:17 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)bse
03 Nov, 01:08 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines".nse
03 Nov, 01:03 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
23 Oct, 05:11 pmAlkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On 13Th November, 2025bse
01 Oct, 03:11 pmAlkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Orderbse
01 Oct, 03:06 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
26 Sept, 05:28 pmAlkem Laboratories Ltd - 539523 - Announcement Under Reg 30 (LODR)- Alkem Laboratories Limited Entered Into A Business Transfer Agreement With Alkem Wellness Limited, A Wholly Owned Subsidiary Of The Company.bse
26 Sept, 05:16 pmAlkem Laboratories Limited has informed the Exchange about General Updatesnse
25 Sept, 03:33 pmAlkem Laboratories Limited has informed the Exchange regarding Resignation of Mr Amit Ghare as Senior Management Personnel of the company w.e.f. September 30, 2025.nse
25 Sept, 03:29 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
24 Sept, 02:30 pmAlkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Orderbse
24 Sept, 02:26 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
22 Sept, 08:32 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
22 Sept, 08:30 pmAlkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Orderbse
22 Sept, 04:04 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
22 Sept, 04:01 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated September 22, 2025, titled "Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer.".nse
09 Sept, 12:28 pmAlkem Laboratories Ltd - 539523 - Announcement Under Reg 30 (LODR)- Cancellation Of Analyst / Institutional Investor Meeting Scheduled On Tuesday, 09Th September, 2025.bse
09 Sept, 12:22 pmAlkem Laboratories Limited has informed the Exchange about Cancellation of Analyst / Institutional Investor Meeting scheduled on Tuesday, 09th September, 2025nse